Pergamon

Journal of Substance Abuse Treatment, Vol. 11, No. 6, pp. III-VI, 1994 Copyright 0 1994 Elsevier Science Ltd Printed in the USA. All rights reserved

0740-5472/94 $6.00 + .oO

Author Index

Volume 11, 1994

Note: Book reviews are indicated as [br]; video reviews are indicated as [vr]; letters to the editor are indicated as [let].

Alper, K., 481 Delucchi, K.L., 9, 225 Alter, C.L., [let] 62 Des Jarlais, D.C., [let] 61, 109 Alterman, A.I., 233, 415 Deucher, R., [let] 62 Argeriou, M., 359 Dilts, S.L., 113 Arrington, K., 525 Astrachan, B.M., 131 Auriacombe, M., 565 Avants, S.K., 549

Baer, J.S., 143 Banys, P., 9, 225 Belkin, B.M., 387 Bennett, M.E., 569 Berry, J.W., 503 Bigler, M.O., 481 Blow, F.C., 239 Blume, T.W., 197 Boatler, J.F., 367 Booth, B.M., 239 Brabant, M., 457 Bradley, C.J., 433 Brewington, V., 205, 289 Brower, K.J., 319 Bruneau, J., 457 Bryant, K.J., 131 Bunn, J.Y., 239 Burman, S., 121

Callaway, E., 9 Cami, J., 463 Carlson, H.B., 113 Chang, G., 131 Chappel, J.N., 99, 137 Chatham, L.R., 217 Chen, I.-L., [let] 62 Childress, A.R., 17 Clark, H.W., 9 Closser, M.H., 319 Cnaan, R.A., 541 Condelli, W.S., 25 Craig, J.M., 267 Craig, R.J., [br] 491

Daley, M., 359 Dansereau, D.F., 517 Daulouede, J.-P., 565 Dees, S.M., 517

Ehrman, R., 17 Elk, R., [let] 61 Engelhart, P., 449

Faulkner, L.R., 267 Fernandez, T., 463 Finkelstein, I., 449 Finn, P., 325 Foote, J., 525 Fornari, V.M., [let] 45, 62 Frankenstein, W., 569 French, M.T., 433 Fromme, K., 143 Fureman, I., 233

Gazzini, J.C., [vr] 167 Geringer, W., 481 Gibbons, R., 387 Clover, N.M., 177 Godley, M.D., 309 Godley, S.H., 309 Gold, MS., 93 Gonzalez, I., 481 Goodman, B., 45 Gossop, M., 463 Gottlieb, L.D., 253 Grabot, D., 565 Grabowski, J., [let] 61, 425 Green, S., 197

Haber, L., 55 Hagman, G., 405 Halpert, E.S., 55 Handelsman, L., 525 Hertzman, M., [br] 63, [br] 393, [br] 492, [br] 589 Hirsch, R., 67, 169, 281, 397, 497, 595 Hitzig, P., [let] 489 Horwitz, R.I., 253 Hsu, C.449 Hubbard, R.L., 25

IV Index

Imhof, J.E., 75, [br] 591 Inaba, D., 503 Ireland, S.J., 55

Janikowski, T.P., 177 Jennings, W., [let] 61 Joanning, H., 197 Joe, G.W., 217 Johnson, N.P., 105, 137 Johnson, S.B., 259

Kabo, L., 45 Kasim, R.M., 373 Kaskutas, L.A., 185 Keller, D.S., 569 Kent, J.D., 45, 247 Khantzian, E.J., 77 Kivlahan, D.R., 143 Kleinman, P.H., 449 Knight, K., 367 Kosten, T.R., 549 Kraus, M.L., 253

Lachance, N., 457 Lamothe, F., 457 Lauzon, P., 457 Leccese, M., 553 Leshner, A.I., 583 Lesser, M., 449 Lieb, R.J., 35 Lipton, D.S., 205, 289 Little, L.M., 347 Lovejoy, M., 525 Loveland-Cook, C.A., 239

Mack, J.E., 77 MacRae, J., 17 Magma, S., 525 Malow, R.M., 55 Margolin, A., 549 Marlatt, G.A., 143 Mavis, B.E., 373 McAleenan, K.A., 239 McCartney, J., 155 McCarty, D., 359 McCrady, B.S., 569 McLellan, A.T., 17, 233, 443, 541 McMahon, R.C., 55 Metzger, D.S., 415, 443 Miller, F.T., 127 Miller, K.J., 339 Miller, N.S., 387 Milling, R.N., 267 Millman, R.B., 449 Mongan, L., 9 Morrison, A., 503 Mulvey, K., 359

O’Brien, C.P., 17, 565 O’Connor, L.E., 503

Paulus, M.D., 569 Pratt, A., 309

Quinn, W.S., 197

Rachal, J.V., 433 Radcliff, S., 113 Randall, M., 541 Ravndal, E., 471 Reilly, P.M., 225 Rhoades, H., [let] 61, 425 Robinson, H., 449 Rosenblum, A., 525 Rosenthal, M.S., 3, 481 Rothman, R.B., [let] 273 Rowan-Szal, G., 217 Rutherford, M.J., 415

San, L., 463 Schliebner, C.T., 511 Schmitz, J.M., [let] 61, 425 Sees, K.L., 9, 225 Segal, S.R., 253 Seligman, M., 525 Sheppard, S.G., 379 Simpson, D.D., 217, 367, 517 Simpson, T.L., 347 Smith, D.E., 111 Smith, M., 205, 289, [let] 587 Soto, J., 457 Spiga, R., [let] 61 Stewart, P., 9 Stimmel, B., 525 Stoffelmayr, B.E., 373 Szapocznik, J., 55

Tan, E., 259 Tignol, J., 565 Trujillo, M., 347 Tusel, D.J., 9, 225

Vaglum, P., 471 Vergnolle, J.-P., 565 Vincelette, J., 457 Viscoli, C.M., 253

Waldron, H.B., 553 Wallace, J.L., 309 Weddington, W.W., [br] 277 Weiss, J., 503 Westerberg, V.S., 347 Willenbring, M.L., 259

Young, N.P., 35 Natale, M., 17 Newman, R.G., [let] 61 Zanis, D.A., 443, 541

VI Index

maintenance treatment, 565 mapping, 5 17 medical inpatients, 259 methadone, 217, 225, 413, 415, 443, 457, 463, 481, 525 methadone maintenance, 247, 425 methadone withdrawal, 9 mid-life, 45 minorities, 55 mood states, 17 multicultural clients, 325 multiple discriminant function, 443 Munchausen’s syndrome, 247

needle sharing, 449 node-link maps, 517

obstacles, 177 opiate abusers, 17 opiate detoxification, 225 opiate withdrawal. 379, 463 opiates, 413 opioid dependence, 565 opioid detoxification, 9 outcomes, 25 outpatient treatment, 131

paired comparisons, 425 parental, 415 physical illness, 247 physician impairment, 1 I3 placebo, 205 pregnant women, 55 prevention, 143 program evaluation, 309 psychodynamic, 35

quiz, 233

recognition, 267 recovery, 195, 503 reinforcement, 217 reinforcer, 425

relapse prevention, 253 relaxation, 549 reliability, 541 research, 289 retention, 25, 525

schizophrenia, 387 SCL-90, 415 self-care, 77 Self-governance, 77 self-help groups, 113 self-repair, 77 shame, 503 skills training, 143 social 113 support, societal expectations, 511 student, 569 substance abuse, 113, 177, 197, 247, 289, 347, 367, 379,

471, 511, 541, 553 substance-abuse treatment, 35 substance dependence, 319 substance use, 415, 553 substance withdrawal, 319 substance withdrawal syndrome, 379 systems-dynamic, 155

Temgesicm, 9 theory, 339 therapeutic communities, 25 therapeutic community, 471 therapy, 155 training, 233 treatment, 35, 195, 267, 339, 413, 443, 569 treatment-efficacy, 463 treatment evaluation, 565 treatment response, 471

validity, 359, 373, 541 visual representations, 5 17

withdrawal, 17 women’s alcohol treatment, 121 women, 195, 339, 511